CAMP and bacterial infectious disease: In addition, LL-37 may interfere with bacterial components that stimulate the activation of TLRs that promote strong inflammatory responses [54]; the production of LL-37 in the limbo-corneal fibroblasts may therefore contribute to the reduction of inflammation associated with the bacterial infection.